期刊文献+

过氧化物酶体增殖物激活受体与自身免疫性疾病 被引量:3

原文传递
导出
摘要 过氧化物酶体增殖物激活受体(peroxisome proliferators activated receptors, PPARs)属于核激素受体超家族(包括类固醇、视黄醇和甲状腺激素受体)中的一类由配体激活的转录因子。PPARs是1990年首先由Issemann等从小鼠肝脏克隆得到,因被过氧化物酶体增殖物活化后能诱导肝脏过氧化物酶体增殖而得名。迄今为止,已知的PPARs有3种亚型:
作者 徐蓓 厉小梅
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第3期197-200,共4页 Chinese Journal of Rheumatology
基金 基金项目:国家自然科学基金(30872340) 安徽省国际科技合作计划(08080703027) 安徽省高层次人才创新创业资金(090413129)
  • 相关文献

参考文献29

  • 1Desvergne B, Wahli W. Peroxisome proliferator -activated receptors: nuclear control of metabolism. Endoer Rev, 1999, 20: 649-688.
  • 2Cuzzoerea S, Di Paola R, Mazzon E, et al. Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest, 2004, 84: 1643-1654.
  • 3Chen NG, Han X. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. Biochem Biophys Res Commun, 2001, 282: 717-722.
  • 4Chinettl G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads betWeen lipid metabolism and inflammation. Inflamm Res, 2000, 49 : 497-505.
  • 5Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monoeyte inflammatory cytokines. Nature, 1998, 391 : 82-86.
  • 6Lovett-Racke AE, Hussain RZ, Northrop S, et al. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol, 2004, 172: 5790-5798.
  • 7Yang XY, Wang LH, Chen T, et al. Activation of human T lymphocytes is inhibited by peroxisome proliferator activated receptor gamma (PPAR gamma) agonists: PPAR gamma coassociation with transcription factor NFAT. J Biol Chem, 2000, 275:4541-4544.
  • 8Yang Q, Gonzalez FJ. Peroxisome proliferator-activated receptor alpha regulates B lymphocyte development via an indirect pathway in mice. Bioehem Pharmaeol, 2004, 68: 2143-2150.
  • 9Mann KK, Doerre S, Schlezinger JJ, et al. The role of NFkappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis. Mol Phamacol, 2001, 59: 302-309.
  • 10Gosset P, Charbonnier AS, Delerive P, et al. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol, 2001, 31: 2857-2865.

二级参考文献31

  • 1阳晓,张海燕,张亚杰,李幼姬,陈伟英,余学清.PPARγ和α-SMA在单侧输尿管梗阻大鼠肾组织中的表达及其意义[J].中国危重病急救医学,2005,17(10):611-614. 被引量:13
  • 2Bordji K, Grillasca JP, Gouze JN, et al. Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPAR gamma activation modulates the effects of interleukin-1 beta on rat chondrocytes. J Biol Chem, 2000, 275: 12243-12250.
  • 3Fahmi H, Di Battista JA, Pelletier JP, et al. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-1 beta-induced nitric oxide and matrix metalloproteinase13 production in human chondrocytes. Arthritis Rheum, 2001, 44: 595- 607.
  • 4Escher P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res, 2000, 44-8: 121-138.
  • 5Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol, 2000, 40: 491-518.
  • 6Shan ZZ, Masuko-Hongo K, Dai SM, et al. A potential role of 15-deoxy-delta ( 12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. J Biol Chem, 2004, 279: 37939-37950.
  • 7Pelletier JP, Jovanovic D, Fernandes JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum, 1998, 41: 1275-1286.
  • 8Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 1990, 347: 645-650.
  • 9Hashimoto S, Setareh M, Ochs RL, et al. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum, 1997, 40: 1749-1755.
  • 10Yatsugi N, Tsukazaki T, Osaki M, et al. Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci, 2000, 5: 150-156.

共引文献7

同被引文献35

  • 1Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue disease- related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum, 2005, 53: 549-557.
  • 2Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic inter- stitial pneumonia: idiopathic versus collagen vascular disease- related subtypes. Am J Respir Crit Care Med, 2007, 175:705-711.
  • 3De Lauretis A, Veeraraghavan S, Renzoni E. Review series: aspects of interstitial lung disease: connective tissue disease- associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis,2011, 8: 53-82.
  • 4Bartram U, Speer CP. The role of transforming growth faetor beta in lung development and disease. Chest, 2004, 125: 754-765.
  • 5Tan X, Dagher H, Hutton CA, et al. Effects of PPAR gamma ligands on TGF-betal-induced epithelial-mesenchymal transition in alveolar epithelial cells. Respir Res, 2010, 11: 21.
  • 6Milam JE, Keshamouni VG, Phan SH, et al. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol I-ng Cell Mol Physiol, 2008, 294: L891-L901.
  • 7Genovese T, Cuzzocrea S, di Paola R, et al. Effect of rosiglita- zone and 15-deoxy-Deltal2, 14-prostaglandin J2 on bleomycin- induced lung injury. Eur Respir J, 2005, 25 : 225-234.
  • 8Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol, 2002, 282: L585-L593.
  • 9Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol, 2004, 85: 47-64.
  • 10Ghosh AK, Bhattaeharyya S, Wei J, et al. Peroxisome proli- ferator-aetivated receptor-gamma abrogates Smad--dependent colla- gen stimulation by targeting the p300 transcriptional eoaetivator. FASEB J, 2009, 23: 2968-2977.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部